China Sky One Medical to Attend Two Conferences in March

HARBIN, China, March 13 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People’s Republic of China ("PRC"), today announced that Ms. Xiao-yan Han, China Sky One Medical Vice President & Director, will attend the Piper Jaffray & ChinaVenture Conference in Shanghai and The World Money Show Hong Kong next week. The dates of the conferences are as follows:

Piper Jaffray & ChinaVenture Conference

Date: March 16-17, 2009

Location: Grand Hyatt, Shanghai

Information regarding the schedule and featured speakers will be posted to the conference Web site at http://events.chinaventure.com.cn/sh2009_en/ticket.aspx .

The World Money Show Hong Kong

Date: March 17-19, 2009

Location: Grand Hyatt, Hong Kong

Ms. Han will join the panel discussion hosted by Crocker Coulson, President of CCG Investor Relations, titled 'China Rising: Investment Opportunities in US-listed Chinese Companies,' on March 18, 2009, from 11:15 AM - 12:00 PM.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute

forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the participation of investment conferences. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People’s Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

For more information, please contact:

Company Contact:

China Sky One Medical, Inc.

Mr. Yu-Bo Hao, CFO

Tel: +86-0451-53994069

Email: china_sky_one@yahoo.cn

Investor Relations Contact:

CCG Investor Relations

Mr. Crocker Coulson, President

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

Web: http://www.ccgirasia.com